SELB - Selecta Biosciences Inc
Close
0.88
0.880 100.000%
Share volume: 0
Last Updated: Mon 13 Nov 2023 09:12:48 PM CET
Pharmaceutical Preparation Manufacturing :
2.75%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
60%
Profitability
68%
Dept financing
38%
Liquidity
28%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-1815.1%
Return on assets
-20.66%
Return on sales
0%
Return on invested capital
126.65%
Total debt ratio
72.05%
Debt ratio change over timeo
0.08%
Current Ratio
4.63%
Quick Ratio
0%
Cash Position Ratio
3.35%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
118.78%
Return on assets
-21.35%
Return on sales
0%
Return on invested capital
126.39%
Total debt ratio
107.8%
Debt ratio change over timeo
0.83%
Current Ratio
2.29%
Quick Ratio
0%
Cash Position Ratio
2.21%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
184.5%
Return on assets
-21.76%
Return on sales
0%
Return on invested capital
288.19%
Total debt ratio
117.35%
Debt ratio change over time
-0.06%
Current Ratio
2.71%
Quick Ratio
0%
Cash Position Ratio
2.67%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-4913.05%
Return on assets
-128.48%
Return on sales
0%
Return on invested capital
19.5%
Total debt ratio
7.59%
Debt ratio change over time
0.08%
Current Ratio
3.01%
Quick Ratio
0%
Cash Position Ratio
1.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SELB | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -1815.1% | 0% | 0% | 29.06% |
| Return on assets | -20.66% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 126.65% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 34% |
| Total debt ratio | 72.05% | 0% | 0% | 183.15% |
| Debt ratio change over time | 0.08% | 0% | 0% | 19.02% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 2.29% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.21% | 0% | 0% | 5.68% |
| Liquididy | 46% | 0% | 0% | 71% |
| Short-term ratios | SELB | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 118.78% | 0% | 0% | -16.12% |
| Return on assets | -21.35% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 126.39% | 0% | 0% | 96.56% |
| Profitability | 75% | 0% | 25% | 19% |
| Total debt ratio | 107.8% | 0% | 0% | 79.61% |
| Debt ratio change over time | 0.83% | 0% | 0% | 0.09% |
| Dept financing | 50% | 0% | 0% | 21% |
| Current Ratio | 2.29% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.21% | 0% | 0% | 5.68% |
| Liquididy | 19% | 0% | 0% | 75% |